LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Black Grain Eumycetoma Causative Agents Identified by Molecular Method

By LabMedica International staff writers
Posted on 17 Dec 2014
Image: Histopathological appearance of Black Grain Eumycetoma caused by Madurella mycetomatis (Photo courtesy of Dr. Libero Ajello).
Image: Histopathological appearance of Black Grain Eumycetoma caused by Madurella mycetomatis (Photo courtesy of Dr. Libero Ajello).
A rapid, simple, and highly efficient molecular based method for identification of the causative agents of black grain eumycetoma has been introduced, aiming to improve diagnostics in endemic areas.

Accurate identification of mycetoma causative agent is a priority for treatment; however, current identification tools are far from being satisfactory for both reliable diagnosis and epidemiological investigations and the currently available molecular methods based on DNA sequencing though specific are extremely expensive.

Scientists at the University of Amsterdam (The Netherlands) collaborating with an international team, analyzed 62 isolates belonging to eight species causing black grain mycetoma: 32 Madurella mycetomatis, 1 M. fahalii , 3 M. pseudomycetomatis, 2 M. tropicana, 10 Trematosphaeria grisea, 6 Falciformispora senegalensis, 2 F. tompkinsii, and 6 Medicopsis romeroi. All strains were identified down to species level by sequencing of the ribosomal DNA (rDNA) internal transcribed spacer (ITS) region.

Rolling circle amplification (RCA) is a powerful diagnostic method based on detection of specific nucleic-acid sequences and enzymatic amplification of circularized oligonucleotide probes under isothermal conditions. The probes are linear oligonucleotides that contain two target-complementary sequences at their ends joined by linkers. The ends of the probe hybridize to the complementary target in juxtaposition and then ligate which allows the circularization of the probe. The circular structured molecule then amplifies with DNA polymerase that has strand displacement and progressive DNA synthesis activity resulting in series of repeats of the original circular template. After RCA, accumulated double stranded DNA was detected with an ultra violet (UV) transilluminator (Vilber Lourmat; Marne-la-Vallée, France).

RCA was used to identify 62 strains belonging to eight species causing human eumycetoma. Since black grain eumycetoma species are known to be phylogenetically distant, it was easy to find unique sites for their identification. The ribosomal ITS region was sufficient for identification of all species and showed no intraspecific variability within a set of 100 M. mycetomatis strains in the collection. With the isothermal RCA assay, the 62 isolates were successfully identified with 100% specificity and no cross reactivity or false results.

The authors concluded that RCA is extremely useful for specific identification of agents of mycetoma. Performance and rapid turnaround time features make the RCA suitable for quick and reliable diagnosis, which is an enormous improvement compared to the current phenotypic identification of mostly non-sporulating cultures. Future application of RCA could be the detection of agents DNA directly from clinical samples without requirement of culturing. The study was published on December 4, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Amsterdam 
Vilber Lourmat 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
8-Channel Pipette
SAPPHIRE 20–300 µL

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more